Understanding and treating vision loss in glaucoma
The role of impaired mitophagy and mitochondrial dysfunction in glaucomatous neurodegeneration
This project looks at how problems with cell energy factories, called mitochondria, contribute to glaucoma and explores new ways to protect vision.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11131025 on NIH RePORTER |
What this research studies
Glaucoma is a common eye condition that causes irreversible vision loss by damaging nerve cells in the eye. We know that high eye pressure is a major risk factor, but we don't fully understand why these nerve cells die. This project uses advanced mouse models that mimic human glaucoma to uncover the specific molecular changes happening in the eye. We are focusing on how damaged mitochondria, the powerhouses of our cells, accumulate and contribute to nerve cell loss. Our goal is to find ways to improve the cell's ability to clean up these damaged mitochondria, which could lead to new treatments.
Who could benefit from this research
Good fit: This foundational research is for patients interested in the underlying causes of primary open angle glaucoma and future treatment developments.
Not a fit: Patients seeking immediate clinical intervention or direct participation in a treatment trial would not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to new treatment strategies that prevent nerve cell loss and preserve vision for people with glaucoma.
How similar studies have performed: While the role of mitochondrial dysfunction in neurodegenerative diseases is an active area of investigation, this specific approach to enhancing mitophagy in glaucoma models is a novel and promising direction.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Maddineni, Prabhavathi — University of Missouri-Columbia
- Study coordinator: Maddineni, Prabhavathi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.